- Home
- CHMI vs INMB Comparison
CHMI vs INMB Comparison
Compare CHMI & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHMI
- INMB
- Stock Information
- Founded
- CHMI 2012
- INMB 2015
- Country
- CHMI United States
- INMB United States
- Employees
- CHMI N/A
- INMB N/A
- Industry
- CHMI Real Estate Investment Trusts
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- CHMI Real Estate
- INMB Health Care
- Exchange
- CHMI Nasdaq
- INMB Nasdaq
- Market Cap
- CHMI 97.2M
- INMB 103.3M
- IPO Year
- CHMI 2013
- INMB 2019
- Fundamental
- Price
- CHMI $2.73
- INMB $4.96
- Analyst Decision
- CHMI Buy
- INMB Strong Buy
- Analyst Count
- CHMI 2
- INMB 2
- Target Price
- CHMI $5.00
- INMB $21.00
- AVG Volume (30 Days)
- CHMI 235.2K
- INMB 252.2K
- Earning Date
- CHMI 11-12-2024
- INMB 10-31-2024
- Dividend Yield
- CHMI 21.98%
- INMB N/A
- EPS Growth
- CHMI N/A
- INMB N/A
- EPS
- CHMI N/A
- INMB N/A
- Revenue
- CHMI N/A
- INMB $42,000.00
- Revenue This Year
- CHMI N/A
- INMB N/A
- Revenue Next Year
- CHMI $12.15
- INMB N/A
- P/E Ratio
- CHMI N/A
- INMB N/A
- Revenue Growth
- CHMI N/A
- INMB N/A
- 52 Week Low
- CHMI $2.71
- INMB $4.78
- 52 Week High
- CHMI $4.39
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- CHMI 13.96
- INMB 36.75
- Support Level
- CHMI $3.21
- INMB $6.09
- Resistance Level
- CHMI $3.30
- INMB $6.26
- Average True Range (ATR)
- CHMI 0.10
- INMB 0.38
- MACD
- CHMI -0.05
- INMB -0.10
- Stochastic Oscillator
- CHMI 2.86
- INMB 2.57
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.